Comparison between Roche Integra 400 plus and Abbott Architect ci8200 in Alanine aminotransferase assay

Background: The aim of this work is to present the results of a comparative study between the ALT assay on Integra 400 plus Roche Diagnostic versus Architect ci8200 of Abbott Diagnostic. Methods: A total of 200 patients hospitalized in the various departments of the university hospital Mohammed VI o...

Full description

Bibliographic Details
Main Authors: Somiya Lamrabat, Amina Lyagoubi, Ouardia Bouayadi, Jalila Elmalki, Khadija Elkouche, Mohammed Bensalah, Mohammed Choukri
Format: Article
Language:English
Published: Elsevier 2019-05-01
Series:Practical Laboratory Medicine
Online Access:http://www.sciencedirect.com/science/article/pii/S2352551718301483
Description
Summary:Background: The aim of this work is to present the results of a comparative study between the ALT assay on Integra 400 plus Roche Diagnostic versus Architect ci8200 of Abbott Diagnostic. Methods: A total of 200 patients hospitalized in the various departments of the university hospital Mohammed VI of Oujda were prospectively tested on two systems: Abbott Architect ci8200 and Roche Integra 400 plus. Both analyzers use the spectrophotometric technique by coupling the transamination reaction to the oxidation-reduction reaction at NAD. The agreement of the results between the different techniques was evaluated using the Bland-Altman difference diagram and the Passing-Bablok and Deming regression line. Results: There was a high concordance between the two assays: the equation of the Passing-Bablok line is YArchitect ​= ​−0,5625 ​+ ​0,9917 XIntegra with a correlation coefficient r2 = 0.999. The Bland-Altman diagram shows that the mean bias between the two methods is of the order of 1.1 IU/L and the difference between the ALT measurements by Architect and Integra is in the range of −1.4 to 3.6. Conclusion: Our study shows a high correlation of the ALT assay results between the architect ci8200 and Integra 400 plus. Keywords: Alanine aminotransferase, Comparison, Concordance, Roche diagnostic, Abbott diagnostic
ISSN:2352-5517